Answers are grounded in this paper and cite their sources.
A very short and efficient synthesis of the important drug candidate telaprevir, featuring a biocatalytic desymmetrization and two multicomponent reactions as the key steps, is presented. The classical issue of lack of stereoselectivity in Ugi- and Passerini-type reactions is circumvented. The atom economic and convergent nature of the synthetic strategy require only very limited use of protective groups.
No takes yet. Share an insight, caveat, or question.
Znabet et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: